Not FDA-approved Bones & muscles

Follistatin-344

Follistatin-344 is a myostatin-inhibiting peptide. It is filed in this library under bones & muscles, a navigation topic rather than a statement of where it acts. As a regulatory matter it is not approved by the FDA for any use.

Regulatory status

Follistatin-344 is not approved by the FDA for any use.

It is sold outside the approved-drug system, which means no regulator has reviewed its manufacturing, its purity or its effects.

The evidence

What has actually been published

4 sources on Follistatin-344 published between 1997 and 2017, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on bones & muscles

Start with your own numbers.

Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.

See the OPTML Score

Educational reference only. This page explains what has been published about Follistatin-344. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides